Statistics
Total Visits
| Views | |
|---|---|
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 179 |
Total Visits Per Month
| February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
|---|---|---|---|---|---|---|---|
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: A hellenic cooperative oncology group study | 1 | 25 | 0 | 8 | 4 | 4 | 5 |
Top country views
| Views | |
|---|---|
| United States | 89 |
| Poland | 54 |
| China | 8 |
| Sweden | 5 |
| France | 3 |
| Ireland | 3 |
| Brazil | 2 |
| India | 2 |
| Mongolia | 2 |
| Ukraine | 2 |
Top cities views
| Views | |
|---|---|
| Warsaw | 54 |
| San Mateo | 25 |
| Louisville | 16 |
| Boardman | 7 |
| San Ramon | 7 |
| Ann Arbor | 6 |
| Ashburn | 4 |
| Beijing | 4 |
| Des Moines | 4 |
| Menlo Park | 4 |